Conversely, in other tumor types, such as hepatocellular carcinoma, agents like ketoconazole and sorafenib paradoxically promote mitophagy through the stabilization of PINK1 and recruitment of parkin, which can culminate in apoptotic cell death [191]. Here, PRKN is linked to neoplasm.